Literature DB >> 10689313

How does HIV cause AIDS? The homing theory.

M W Cloyd1, J J Chen, I Wang.   

Abstract

The mechanism by which HIV causes depletion of CD4+ T cells in infected individuals remains unknown. Numerous theories have been proposed, but none can fully explain all of the events observed to occur in patients. Recent studies have shown that HIV binding to resting CD4+ T cells upregulates L-selectin, causing the cells to home from the blood into lymph nodes at an enhanced rate. It is possible that the disappearance of CD4+ T cells in the blood is actually the result of them leaving the blood, which can help explain the loss of CD4+ T cells in the blood occurring at a much faster rate than in lymphoid tissues. Furthermore, secondary signals through homing receptors received during the homing process induce many of these cells into apoptosis. These cells die in the lymph nodes without producing HIV particles, which can explain the 'bystander effect' observed in the lymph nodes of HIV infected individuals. If this scenario occurs in HIV+ patients, it might explain many of the clinical observations.

Entities:  

Mesh:

Year:  2000        PMID: 10689313     DOI: 10.1016/s1357-4310(99)01663-9

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  14 in total

Review 1.  Antiretroviral drug resistance in human immunodeficiency virus type 2.

Authors:  Michel L Ntemgwa; Thomas d'Aquin Toni; Bluma G Brenner; Ricardo J Camacho; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

2.  Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood.

Authors:  V Müller; A F Marée; R J De Boer
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Distinct chemokine triggers and in vivo migratory paths of fluorescein dye-labeled T Lymphocytes in acutely simian immunodeficiency virus SIVmac251-infected and uninfected macaques.

Authors:  Candice C Clay; Denise S Rodrigues; Danielle J Harvey; Christian M Leutenegger; Ursula Esser
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication.

Authors:  Keith J Micoli; Olga Mamaeva; Sabine C Piller; Jennifer L Barker; George Pan; Eric Hunter; Jay M McDonald
Journal:  Virology       Date:  2005-10-17       Impact factor: 3.616

Review 5.  Positron emission tomography in patients suffering from HIV-1 infection.

Authors:  Mike Sathekge; Ingeborg Goethals; Alex Maes; Christophe van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-07       Impact factor: 9.236

6.  Insight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Yueh-Chiu Chan; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

7.  Serum protein electrophoresis under effective control of HIV-1 disease progression.

Authors:  Adebayo Lawrence Adedeji; Rufus Omotayo Adenikinju; Joshua Olufemi Ajele; Theophilus Ladapo Olawoye
Journal:  EXCLI J       Date:  2014-07-15       Impact factor: 4.068

8.  Lead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Yueh-Chiu Chan; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

9.  Investigation of potent lead for acquired immunodeficiency syndrome from traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Yueh-Chiu Chan; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

10.  Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine.

Authors:  Tzu-Chieh Hung; Kuen-Bao Chen; Hung-Jin Huang; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.